Canadian DIN & Molecule SearchMolecules A–ZDrug ShortagesResourcesHealth Canada WeeklyRequest a Quote

AURO-AZILSARTAN MEDOXOMIL DIN 02547023

Status: Marketed
Holder: AURO PHARMA INC
Molecule: AZILSARTAN MEDOXOMIL (AZILSARTAN MEDOXOMIL POTASSIUM)
Available to quote

Health Canada record

Active ingredient(s)AZILSARTAN MEDOXOMIL (AZILSARTAN MEDOXOMIL POTASSIUM) 80 MG
Dosage formTablet
RouteOral
SchedulePRESCRIPTION
ClassHuman
ATCC09CA09 AZILSARTAN MEDOXOMIL
Original market date26-Feb-2025
Current status date26-Feb-2025
SourceHealth Canada DPD

Establishment licence of the holder

Auro Pharma Inc — licence 101305, currently licensed, last inspection rating C (2023-09-27).

No Canadian shortage report is currently matched to this DIN.

Other Canadian products containing AZILSARTAN MEDOXOMIL (AZILSARTAN MEDOXOMIL POTASSIUM)

DINProductCompanyFormStrengthStatus
02547015AURO-AZILSARTAN MEDOXOMILAURO PHARMA INCTabletAZILSARTAN MEDOXOMIL (AZILSARTAN MEDOXOMIL POTASSIUM) 40 MGMarketed
02381389EDARBIBAUSCH HEALTH, CANADA INC.TabletAZILSARTAN MEDOXOMIL (AZILSARTAN MEDOXOMIL POTASSIUM) 40 MGMarketed
02381397EDARBIBAUSCH HEALTH, CANADA INC.TabletAZILSARTAN MEDOXOMIL (AZILSARTAN MEDOXOMIL POTASSIUM) 80 MGMarketed
02397749EDARBYCLORBAUSCH HEALTH, CANADA INC.TabletAZILSARTAN MEDOXOMIL (AZILSARTAN MEDOXOMIL POTASSIUM) 40 MG; CHLORTHALIDONE 12.5 MGMarketed
02397765EDARBYCLORBAUSCH HEALTH, CANADA INC.TabletAZILSARTAN MEDOXOMIL (AZILSARTAN MEDOXOMIL POTASSIUM) 40 MG; CHLORTHALIDONE 25 MGMarketed
02397757EDARBYCLORBAUSCH HEALTH, CANADA INC.TabletAZILSARTAN MEDOXOMIL (AZILSARTAN MEDOXOMIL POTASSIUM) 80 MG; CHLORTHALIDONE 12.5 MGDormant

Notices of Compliance

NOCDateSubmissionReason
348982025-02-25Abbreviated New Drug Submission (ANDS)
Request a quote for AURO-AZILSARTAN MEDOXOMIL

How to read a Canadian DIN record